NCT01364922View on ClinicalTrials.gov

Phase 2 Chronic Low Back Pain Study

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Chronic Low Back Pain
Interventions
DRUG

hydrocodone/acetaminophen extended release

DRUG

Placebo

Trial Locations (17)

14221

Site Reference ID/Investigator# 54881, Williamsville

21122

Site Reference ID/Investigator# 54862, Pasadena

30060

Site Reference ID/Investigator# 54879, Marietta

32720

Site Reference ID/Investigator# 54874, DeLand

34677

Site Reference ID/Investigator# 54866, Oldsmar

43302

Site Reference ID/Investigator# 54863, Marion

45227

Site Reference ID/Investigator# 54872, Cincinnati

46383

Site Reference ID/Investigator# 54865, Valparaiso

63141

Site Reference ID/Investigator# 54880, St Louis

66206

Site Reference ID/Investigator# 54782, Prairie Village

76543

Site Reference ID/Investigator# 54745, Killeen

85704

Site Reference ID/Investigator# 54875, Tucson

90717

Site Reference ID/Investigator# 54873, Lomita

91505

Site Reference ID/Investigator# 54877, Burbank

92801

Site Reference ID/Investigator# 54876, Anaheim

02472-3930

Site Reference ID/Investigator# 54878, Watertown

78209-1744

Site Reference ID/Investigator# 54742, San Antonio

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01364922 - Phase 2 Chronic Low Back Pain Study | Biotech Hunter | Biotech Hunter